Science & Enterprise subscription

Follow us on Twitter

  • Results from a clinical trial show a combination of two synthetic antibodies reduces deaths in hospitalized Covid-1…
    about 9 hours ago
  • New post on Science and Enterprise: Antibodies Help Some Hospitalized Covid-19 Patients #Science #Business
    about 9 hours ago
  • ... Crocodile on the Tarcoles River in Costa Rica, for #NaturePhotographyDay ... February 2020.
    about 1 day ago
  • Oystercatcher for #NaturePhotographyDay ... Cape May, New Jersey. June 2019.
    about 1 day ago
  • Two biotechnology companies are designing therapies to deliver edited genes to treat Friedreich’s ataxia and amyotr…
    about 1 day ago

Please share Science & Enterprise

Infographic – Biotech Remains Hottest Venture Sector

Click on image for full-size view (PwC and CB Insights)

18 Apr. 2020. A report on venture capital investments for the first quarter of 2020 shows biotechnology companies remain the largest recipients of venture investor dollars. The latest Moneytree Report (registration required), published this week by accounting-consulting firm PwC and technology intelligence company CB Insights is the source of this weekend’s infographic, continuing our coverage from yesterday.

The MoneyTree report portrays investor interest in industry sectors using heat maps, with darker magenta and burgundy shades indicating more venture dollars and deals. As our chart indicates, biotechnology start-ups attracted the most investor dollars of any sector, between $2.5 and $13 billion during the first quarter of 2020. And two other health care sectors, drug development and therapeutic medical devices were among the top 10 sectors in venture dollar volumes. These numbers reflect a pattern we noted in venture investment reports beginning last year.

Moreover, biotechnology companies also recorded the largest number of deals than any other sector, between 76 and 82 transactions, during the first quarter of the year. But among broad industry sectors, Internet start-ups attracted the largest number of deals with 547, or 43 percent of the 1,271 total, particularly companies offering software as a service. As we noted yesterday, the total number of venture deals in the U.S. declined for the third straight quarter.

More from Science & Enterprise:

  1. Infographic – Biotech Index Dives, Rebounds
  2. Venture Deals, Dollars Fall in Q4 2019; Biotech Stays Hot
  3. Q3 Venture Investing Falls, Biotech Remains Hot

*     *     *

Comments are closed.